United States · Growth startup

Who invested in Datavant

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$80Mraised across 2 rounds since 2018, from 2 sources

$40MRound$40MGrowth
Latest round
Growth, $40MSept 2026
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026
$40MRound$40MGrowth
First round
Round, $40M
Apr 2018
Biggest round
$40M
Growth · Sept 2026
Between rounds
8.3 years
from the last two

The rounds

  1. Sept 2026
    Growth$40M3 new

    Source recorded

  2. Apr 2018
    Round$40M2 new

    Reported by FinSMEs

Founders and team

From Datavant's own website: 14 on the team.

  • Amy AbernethyPresident of Product Development & Chief Medical Officer
  • Kyle ArmbresterChief Executive Officer
  • Conor HortonAssociate Vice President
  • McLeod Physicians AssociatesAssociate Vice President
  • Mark HarrisGM & President, Legal & Insurance
  • Ashley GreenbergChief of Staff
  • Jennifer WilliamsChief Financial Officer
  • Josh BuilderChief Technology Officer
  • Kathryn StalmackChief Legal Officer & General Counsel
  • Sam DiederichChief Product Officer
  • Shannon WestChief Strategy Officer
  • Susan YunChief People Officer
  • Annie HurstHead of Corporate Initiatives
  • Maribeth JimenezOperations Manager

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Growth2026Founders FundGoldman SachsGoldman Sachs AssetmanagementTravis MayRoivant Sciences

Everyone who backed them

Founders FundVC firm1round
Goldman SachsPrivate equity1round
Goldman Sachs AssetmanagementVC firm1round
Travis MayAngel1round
Roivant SciencesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Datavant as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Flex CapitalVC firmPer its own site
Ardan EquityPrivate equityPer its own site
Health Catalyst CapitalPrivate equityPer its own site
ConduitAcceleratorPer its own site
Octave FundVC firmPer its own site

Quick answers about Datavant

Who invested in Datavant?

Datavant's investors include Founders Fund, Goldman Sachs, Goldman Sachs Assetmanagement, Travis May and Roivant Sciences.

How much has Datavant raised?

Datavant has raised $80M across 2 rounds since 2018.

When did Datavant last raise?

Datavant's most recent round was a Growth of $40M in Sept 2026.

What was Datavant's biggest round?

Its most recent round, $40M in Sept 2026, is also its largest on record.

Who backed Datavant first?

Datavant's first round on record, in Apr 2018, was backed by Travis May and Roivant Sciences.

What stage is Datavant at?

Datavant's latest named round is a Growth, in Sept 2026.

Where is Datavant based?

Datavant is based in the United States.

Companies like Datavant

In the same sector, and raised in the last eighteen months.

Star Therapeutics$325M · Oct 2026Promaxo$106M · Oct 2026Prolific Machines$105M · Oct 2026AI$18M · Oct 2026Baba$40M · Oct 2026IMIO$19M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app